A detailed history of Rhenman & Partners Asset Management Ab transactions in Penumbra Inc stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 23,000 shares of PEN stock, worth $4.41 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
23,000
Previous 46,000 50.0%
Holding current value
$4.41 Million
Previous $10.3 Million 59.68%
% of portfolio
0.41%
Previous 1.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$172.27 - $223.95 $3.96 Million - $5.15 Million
-23,000 Reduced 50.0%
23,000 $4.14 Million
Q1 2024

May 14, 2024

BUY
$220.09 - $273.15 $9.57 Million - $11.9 Million
43,500 Added 1740.0%
46,000 $10.3 Million
Q4 2023

Feb 13, 2024

BUY
$181.44 - $260.22 $453,600 - $650,550
2,500 New
2,500 $628,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $7.26B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.